Wai Chun Bio-Technology Limited provided unaudited consolidated earnings guidance for the six months ended June 30, 2021. For the six months, the Group is expected to record a decrease of 60% to 80% in the net profit for the six months ended 30 June 2021 as compared to the corresponding period of the year 2020.